Abstract
We performed a study-level meta-analysis to provide more robust evidence on safety of very low LDL-cholesterol (LDL-C) levels.
| Original language | English |
|---|---|
| Journal | European Heart Journal - Cardiovascular Pharmacotherapy |
| DOIs | |
| Publication status | Published - 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adverse events
- Lipid-lowering therapies
- Major adverse cardiovascular events
- Very low LDL-C
Fingerprint
Dive into the research topics of 'Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver